Latest filing published 21 Feb 2024 for AMEDISYS INC.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Michael Paul North: trading record in brief
All filings by Michael Paul North on record concern Amedisys Inc, in the capacity of senior executive. In total, 73 filings cover trades dated from 20 January 2017 to 20 February 2024.
The open-market record consists of 20 sales worth €8.0M, with no purchase. Other entries cover 36 share grants and 17 option exercises.
On 21 February 2024 came the latest disclosure, a share grant in Amedisys Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Michael Paul North
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,277 shares0Common StockSEC:0000896262-24-000008:0
- 5,908 shares@ US$86.4380.3% of flowCommon StockSEC:0000896262-23-000027:0
- 2,044 shares0Common StockSEC:0000896262-23-000024:0
- 1,302 shares@ US$97.1619.7% of flowCommon StockSEC:0000896262-23-000020:0
- 1,309 shares0Common StockSEC:0000896262-22-000016:0
5 of 5 declarations
